Pharma Companies
-
{
- All
- News
- Videos
- Web Stories
-
Trump's 200% Tariff Threat On Generic Drug Imports: What Does It Mean For India?
The proposed policy provides a transition period until August 2028, after which imported generic drugs would face a 100% tariff for one year before the duty rises to 200%.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Trump Tariffs: Dr Reddy's To Lupin — Pharma Stocks To Be In Focus After Threat Of 200% Levies
Trump's threat of a 200% tariff on pharmaceutical products can have severe implications on Indian drugmakers, as exports to the US form a significant share of their overall sales.
-
Gujarat High Court Orders Probe Into Bulgarian's Rape Charge Against Pharma Firm Head
The Gujarat High Court on Friday directed the chief judicial magistrate to pass an order of investigation in a complaint of rape and human trafficking made by a Bulgarian national against the CMD of a leading Indian pharmaceutical company.
-
Government Bans 328 Combination Drugs In A Blow To Pharma Companies
Combination drugs are used to improve patients' compliance, as it is easier to get patients to take one drug rather than several.
-
Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment
The minister said that India has been recognised as the Pharmacy of the World during the COVID-19 crisis
-
Pharma Companies May Report Strong Revenue Growth For Q1: Jefferies
The pharmaceuticals sector may report strong revenue growth for the first quarter of the current fiscal year, foreign brokerage Jefferies has said in a report.
-
Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why
Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
-
Innovation, Tech Key Factors for Pharma Sector in Emerging Markets: Report
Innovation and technology will be important differentiators as pharmaceutical companies try to drive growth in emerging markets that face rapid growth of various chronic diseases like diabetes, hypertension, heart disease, and cancer, according to a report.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Trump's 200% Tariff Threat On Generic Drug Imports: What Does It Mean For India?
The proposed policy provides a transition period until August 2028, after which imported generic drugs would face a 100% tariff for one year before the duty rises to 200%.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Trump Tariffs: Dr Reddy's To Lupin — Pharma Stocks To Be In Focus After Threat Of 200% Levies
Trump's threat of a 200% tariff on pharmaceutical products can have severe implications on Indian drugmakers, as exports to the US form a significant share of their overall sales.
-
Gujarat High Court Orders Probe Into Bulgarian's Rape Charge Against Pharma Firm Head
The Gujarat High Court on Friday directed the chief judicial magistrate to pass an order of investigation in a complaint of rape and human trafficking made by a Bulgarian national against the CMD of a leading Indian pharmaceutical company.
-
Government Bans 328 Combination Drugs In A Blow To Pharma Companies
Combination drugs are used to improve patients' compliance, as it is easier to get patients to take one drug rather than several.
-
Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment
The minister said that India has been recognised as the Pharmacy of the World during the COVID-19 crisis
-
Pharma Companies May Report Strong Revenue Growth For Q1: Jefferies
The pharmaceuticals sector may report strong revenue growth for the first quarter of the current fiscal year, foreign brokerage Jefferies has said in a report.
-
Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why
Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
-
Innovation, Tech Key Factors for Pharma Sector in Emerging Markets: Report
Innovation and technology will be important differentiators as pharmaceutical companies try to drive growth in emerging markets that face rapid growth of various chronic diseases like diabetes, hypertension, heart disease, and cancer, according to a report.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
